InvestorsHub Logo
Followers 470
Posts 76416
Boards Moderated 3
Alias Born 03/31/2008

Re: None

Thursday, 10/23/2014 6:58:18 AM

Thursday, October 23, 2014 6:58:18 AM

Post# of 648882
ALXN Alexion Pharmaceuticals beats by $0.11, beats on revenue

Alexion Pharmaceuticals (NASDAQ:ALXN): Q3 EPS of $1.27 beats by $0.11.
Revenue of $555.15M (+38.6% Y/Y) beats by $13.22M.
Shares -0.17% PM.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.